We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Terumo and PhotonPharma today announced they have established a memorandum of understanding (MOU) for collaboration to develop Innocell™, a novel tumor specific immunotherapy (a therapeutic vaccine) for solid tumors.